Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Gastroenterology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 17087946
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry

  2006cited by this paper
• Lambda Interferon (IFN-λ), a Type III IFN, Is Induced by Viruses and IFNs and Displays Potent Antiviral Activity against Select Virus Infections In Vivo

  2006cited by this paper
• Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma.

  2006cited by this paper
• SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29.

  2005cited by this paper
• Complete Replication of Hepatitis C Virus in Cell Culture

  2005cited by this paper
• Unravelling hepatitis C virus replication from genome to function

  2005cited by this paper
• Lambda Interferon Inhibits Hepatitis B and C Virus Replication

  2005cited by this paper
• Viral infection and Toll‐like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte‐derived dendritic cells

  2004cited by this paper
• The expanded family of class II cytokines that share the IL‐10 receptor‐2 (IL‐10R2) chain

  2004cited by this paper
• The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions.

  2004cited by this paper
• Full house: 12 receptors for 27 cytokines.

  2004cited by this paper
• Cutting Edge: IL-26 Signals through a Novel Receptor Complex Composed of IL-20 Receptor 1 and IL-10 Receptor 2 1

  2004cited by this paper
• Global effect of PEG-IFN-alpha and ribavirin on gene expression in PBMC in vitro.

  2004cited by this paper
• Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling.

  2004cited by this paper
• Cytopathic and Noncytopathic Interferon Responses in Cells Expressing Hepatitis C Virus Subgenomic Replicons

  2003cited by this paper
• Interleukin-1 Inhibits Hepatitis C Virus Subgenomic RNA Replication by Activation of Extracellular Regulated Kinase Pathway

  2003cited by this paper
• Effector genes of interferon action against hepatitis C virus

  2003cited by this paper
• Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture

  2003cited by this paper
• Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3.

  2003cited by this paper
• Alpha Interferon Induces Distinct Translational Control Programs To Suppress Hepatitis C Virus RNA Replication

  2003cited by this paper
• Synergistic Antiviral Activity of Human Interferon Combinations in the Hepatitis C Virus Replicon System

  2003cited by this paper
• Interferons and Apoptosis

  2003cited by this paper
• IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.

  2003cited by this paper
• Improved biological and transcriptional activity of monopegylated interferon-alpha-2a isomers.

  2003cited by this paper
• Antiviral Effect and Virus-Host Interactions in Response to Alpha Interferon, Gamma Interferon, Poly(I)-Poly(C), Tumor Necrosis Factor Alpha, and Ribavirin in Hepatitis C Virus Subgenomic Replicons

  2003cited by this paper
• Viruses and the TNF-related cytokines, an evolving battle.

  2003cited by this paper
• Hepatitis C virus RNA replication is resistant to tumour necrosis factor-alpha.

  2003cited by this paper
• Hepatitis C advances in antiviral therapy: What is accepted treatment now?

  2002cited by this paper
• Interferon-alpha activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes.

  2002cited by this paper
• Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling.

  2002cited by this paper
• Review: IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry.

  2002cited by this paper
• Mechanisms of Type I interferon cell signaling and STAT-mediated transcriptional responses.

  2002cited by this paper
• Comparative Analysis of Anti-Hepatitis C Virus Activity and Gene Expression Mediated by Alpha, Beta, and Gamma Interferons

  2002cited by this paper
• Tumor Necrosis Factor Alpha Exerts Powerful Anti-Influenza Virus Effects in Lung Epithelial Cells

  2002cited by this paper
• Viruses and interferon: a fight for supremacy

  2002cited by this paper
• Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs.

  2002cited by this paper
• IL-28, IL-29 and their class II cytokine receptor IL-28R

  2002cited by this paper
• Functional classification of interferon‐stimulated genes identified using microarrays

  2001cited by this paper
• Characterization of Cell Lines Carrying Self-Replicating Hepatitis C Virus RNAs

  2001cited by this paper
• Hepatitis C virus infection.

  2001cited by this paper
• Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway.

  2001cited by this paper
• Antiviral Actions of Interferons

  2001cited by this paper
• Effect of Alpha Interferon on the Hepatitis C Virus Replicon

  2001cited by this paper
• Down-modulation of Type 1 Interferon Responses by Receptor Cross-competition for a Shared Jak Kinase*

  2001cited by this paper
• Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures.

  2000cited by this paper
• The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

  1999cited by this paper
• Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays.

  1998cited by this paper
• Therapy of hepatitis C: Alpha interferon and ribavirin

  1997cited by this paper
• Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha.

  1996cited by this paper
• Hepatitis C virus and organ transplantation.

  1996cited by this paper
• Tumor necrosis factor-alpha and interferon-gamma inhibit synergistically viral replication in hepatitis B virus-replicating cells.

  1995cited by this paper
• The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

  1992cited by this paper

• Interferon lambda signaling to maternal dendritic cells protects against congenital Zika virus infection

  2026cites this paper
• Diagnostic and immunological roles of leptin gene rs7799039 polymorphism and cytokines in COVID-19, HCV, and dual infection

  2026cites this paper
• Cholesterol 25-hydroxylase inhibits Newcastle disease virus replication by its architectural damage and blocking HN protein.

  2025cites this paper
• Ubiquitin-specific proteases in hepatitis: bridging molecular mechanisms and therapeutic potential

  2025cites this paper
• Interferons in Sjogren's disease: current status and future prospects.

  2025cites this paper
• Interferon signaling in the nasal epithelium distinguishes among lethal and common cold coronaviruses and mediates viral clearance

  2024cites this paper
• Antiviral and Immunomodulatory Effects of Interferon Lambda at the Maternal-Fetal Interface.

  2024cites this paper
• Harnessing the power of IFN for therapeutic approaches to COVID-19

  2024cites this paper
• Like a Rolling Stone? A Review on Spontaneous Clearance of Hepatitis C Virus Infection

  2024cites this paper
• Synthetic Heterodimers of Type III Interferon Receptors Require TYK2 for STAT Activation

  2023cites this paper
• Liver fibrosis in fish research: From an immunological perspective.

  2023cites this paper
• Zebrafish-based platform for emerging bio-contaminants and virus inactivation research

  2023cites this paper
• In HIV-Infected Immunological Non-Responders, Hepatitis C Virus Eradication Contributes to Incomplete Normalization of Systemic Inflammation Indexes, but Does Not Lead to Rapid CD4+ T-Cell Count Recovery

  2023cites this paper
• Interferon lambda modulates proinflammatory cytokines production in PBMCs from patients with chronic kidney disease.

  2023cites this paper
• Role of Innate Interferon Responses at the Ocular Surface in Herpes Simplex Virus-1-Induced Herpetic Stromal Keratitis

  2023cites this paper
• Highly multiplexed mRNA quantitation with CRISPR-Cas13

  2023cites this paper
• Susceptibilidad genética y aclaramiento viral de la infección por Virus de la Hepatitis C

  2023cites this paper
• The role and application of three IFN-related reactions in psoriasis.

  2023cites this paper
• Membrane-proximal motifs encode differences in signaling strength between type I and III interferon receptors

  2023cites this paper
• Pathogenicity of Type I Interferons in Mycobacterium tuberculosis

  2023cites this paper
• Type III and Not Type I Interferons Efficiently Prevent the Spread of Rotavirus in Human Intestinal Epithelial Cells

  2022cites this paper
• Emerging Role of Interferon-Induced Noncoding RNA in Innate Antiviral Immunity

  2022cites this paper
• Reveal the biomarkers and immune in�ltration of dermatomyositis and explore associated diseases as well as drug molecules by bioinformatics analysis

  2022cites this paper
• Mechanisms of immune regulation by the placenta: Role of type I interferon and interferon‐stimulated genes signaling during pregnancy *

  2022cites this paper
• Enhanced TLR3 responsiveness in hepatitis C virus resistant women from the Irish anti-D cohort

  2022cites this paper
• Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas.

  2022cites this paper
• Intracellular mono-ADP-ribosyltransferases at the host–virus interphase

  2022cites this paper
• Constitutive expression and distinct properties of IFN-epsilon protect the female reproductive tract from Zika virus infection

  2022cites this paper
• STAT1 and Its Crucial Role in the Control of Viral Infections

  2022cites this paper
• The gamble between oncolytic virus therapy and IFN

  2022cites this paper
• Antiviral Toll-like Receptor Signaling in Non-Parenchymal Liver Cells Is Restricted to TLR3

  2022cites this paper
• Role of Interferons in Mycobacterium tuberculosis Infection

  2022cites this paper
• Functions of IFNλs in Anti-Bacterial Immunity at Mucosal Barriers

  2022cites this paper
• IFN-λ1 Displays Various Levels of Antiviral Activity In Vitro in a Select Panel of RNA Viruses

  2021cites this paper
• Hepatitis D virus (HDV): investigational therapeutic agents in clinical trials

  2021cites this paper
• Correlation between IL-28 polymorphism and spontaneous clearance in HCV patients: systematic review and meta-analysis

  2021cites this paper
• Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells

  2021cites this paper
• IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease

  2021cites this paper
• Treatment induced clearance of hepatitis E viruses by interferon‐lambda in liver‐humanized mice

  2021cites this paper
• Single nucleotide polymorphisms in PNPLA3, ADAR-1 and IFIH1 are associated with advanced liver fibrosis in patients co-infected with HIV-1//hepatitis C virus

  2021cites this paper
• Placenta‐derived interferon‐stimulated gene 20 controls ZIKA virus infection

  2021cites this paper
• Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients

  2021cites this paper
• B Cell Activation and Plasma Cell Differentiation Are Promoted by IFN-λ in Systemic Lupus Erythematosus

  2021cites this paper
• A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis

  2021cites this paper
• Type III Interferons: Emerging Roles in Autoimmunity

  2021cites this paper
• Compositional biases in RNA viruses: Causes, consequences and applications

  2021cites this paper
• Novel antiviral interferon sensitive genes unveiled by correlation-driven gene selection and integrated systems biology approaches

  2021cites this paper
• The In Vivo Source of Type I and Type III IFNs is Pathogen Dependent

  2021cites this paper
• Conserved Induction of Distinct Antiviral Signalling Kinetics by Primate Interferon Lambda 4 Proteins

  2021cites this paper
• Differential roles of interferons in innate responses to mucosal viral infections

  2021cites this paper
• NS1: A Key Protein in the “Game” Between Influenza A Virus and Host in Innate Immunity

  2021cites this paper
• DDX56 antagonizes IFN-β production to enhance EMCV replication by inhibiting IRF3 nuclear translocation.

  2021cites this paper
• Novel interferon-sensitive genes unveiled by correlation-driven gene selection and systems biology

  2021cites this paper
• INTERFERON- 𝛼 -INDUCED CHANGES TO NATIVE KILLER CELLS ARE RELATED TO THERAPY OUTCOMES IN PATIENTS HAVING HCV INFECTIONS

  2020cites this paper
• Innate Immunity in Hepatitis C Virus Infection.

  2020cites this paper
• Selective interferon responses of intestinal epithelial cells minimize TNFα cytotoxicity

  2020cites this paper
• Differential Induction of Type I and III Interferons by Staphylococcus aureus

  2020cites this paper
• Interferon-λ Enhances the Differentiation of Naive B Cells into Plasmablasts via the mTORC1 Pathway.

  2020cites this paper
• Type III Interferons (Lambda Interferons) in Rheumatic Autoimmune Diseases

  2020cites this paper
• High-risk Allele for Herpes Labialis Severity at the IFNL3/4 Locus is Associated With Vestibular Neuritis

  2020influential citation
• The pattern of antiviral protein expression induced by interferon λ1 in peripheral blood mononuclear cells of patients with chronic hepatitis C virus infection

  2020cites this paper
• Interferon-γ inducible protein-10 and interleukin 28B gene polymorphism as predictive markers for genotype 4 hepatitis C virus treatment response.

  2020cites this paper
• Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons

  2020cites this paper
• Selective Interferon Responses of Intestinal Epithelial Cells Minimize Tumor Necrosis Factor Alpha Cytotoxicity

  2020cites this paper
• Mechanisms of Innate Immune Activation by a Hybrid Alphavirus–Rhabdovirus Vaccine Platform

  2020cites this paper
• The dramatic role of IFN family in aberrant inflammatory osteolysis.

  2020cites this paper
• The pros and cons of interferons for oncolytic virotherapy.

  2020cites this paper
• Comparative transcriptomic and proteomic analyses proved IFN-λ1 is a more potent inducer of ISGs than IFN-α against porcine epidemic diarrhea virus in porcine intestinal epithelia cells.

  2020cites this paper
• The Key Roles of Interferon Lambda in Human Molecular Defense against Respiratory Viral Infections

  2020cites this paper
• In-vivo Activity of IFN-λ and IFN-α Against Bovine-Viral-Diarrhea Virus in a Mouse Model

  2020cites this paper
• Immune response in SARS-CoV-2 infection: the role of interferons type I and type III

  2020cites this paper
• Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces

  2020cites this paper
• Targeting IL-10 Family Cytokines for the Treatment of Human Diseases.

  2019cites this paper
• Interferon Lambda: Toward a Dual Role in Cancer

  2019cites this paper
• Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion

  2019cites this paper
• Web of interferon stimulated antiviral factors to control the influenza A viruses replication.

  2019cites this paper
• Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and III Interferons.

  2019influential citation
• Lambda interferons in immunity and autoimmunity.

  2019cites this paper
• Anti‐viral effects of interferon‐λ3 on hepatitis B virus infection in cell culture

  2019cites this paper
• Type-Specific Crosstalk Modulates Interferon Signaling in Intestinal Epithelial Cells

  2019cites this paper
• Individual liver plasmacytoid dendritic cells are capable of producing IFNα and multiple additional cytokines during chronic HCV infection

  2019cites this paper
• Two Distinct Immune Pathways Linking Social Relationships With Health: Inflammatory and Antiviral Processes.

  2019cites this paper
• ZBP1 mediates interferon-induced necroptosis

  2019cites this paper
• Shared and Distinct Functions of Type I and Type III Interferons.

  2019cites this paper
• Illuminating novel aspects in virus-host interactions by tailored quantitative proteomics analyses

  2019cites this paper
• TRIM27 Promotes Hepatitis C Virus Replication by Suppressing Type I Interferon Response

  2019cites this paper
• Interferon-Inducible Myxovirus Resistance Proteins: Potential Biomarkers for Differentiating Viral from Bacterial Infections

  2019cites this paper
• Dynamic Expression of Interferon Lambda Regulated Genes in Primary Fibroblasts and Immune Organs of the Chicken

  2019cites this paper
• Differential Regulation of Type I and Type III Interferon Signaling

  2019cites this paper
• Targeting STATs in neuroinflammation: The road less traveled!

  2019cites this paper
• IL28B, IL29 and micro-RNA 548 in subacute sclerosing panencephalitis as a rare disease.

  2018cites this paper
• Comprehensive Proteomics Identification of IFN-λ3-regulated Antiviral Proteins in HBV-transfected Cells*

  2018cites this paper
• Brain region-specific expression of genes mapped within quantitative trait loci for behavioral responsiveness to acute stress in Fisher 344 and Wistar Kyoto male rats

  2018cites this paper
• Genetic Polymorphisms within Interferon-λ Region and Interferon-λ3 in the Human Pathophysiology: Their Contribution to Outcome, Treatment, and Prevention of Infections with Hepatotropic Viruses.

  2018cites this paper
• Hepatitis B and C.

  2018cites this paper
• IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway

  2018cites this paper
• English Version

  2018cites this paper
• MicroRNA-122 supports robust innate immunity in hepatocytes by suppressing STAT3 phosphorylation

  2018cites this paper
• Type III Interferons in Viral Infection and Antiviral Immunity

  2018cites this paper
• Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance

  2018cites this paper